Measures of left ventricular end diastolic and left ventricular end systolic diameters (LVEDD, LVESD) used to determine cardiac dilatation showed that neither doxorubicin nor Trpc6 deficiency led to dilated cardiomyopathy at this time point in males (Figures 4G,H). The gene discussed is TRPC6; the disease is dilated cardiomyopathy.